IL1B and neoplasm: Taken together, while anti-IL-1β treatment appears to enhance the CAF and immune cell infiltration in the KPC tumor with lung metastasis potential, it appears to suppress the function of CAF and immune cells in the KPC tumor with liver metastasis potential.